Nevertheless, for BTLA+ T cells coexpressing sCTLA-4 or cCTLA-4 molecules, we found the significantly higher proportions in the CLL group as compared to the controls (p = 0.006 or p = 0.006, respectively; Figure 5). The gene discussed is BTLA; the disease is B-cell chronic lymphocytic leukemia.